Hisamitsu Pharmaceutical Co Financial Overview
Hisamitsu Pharmaceutical Co's market cap is currently $1.97B. The company's EPS TTM is $0.40844205; its P/E ratio is 15.10; and it has a dividend yield of 2.58%. Hisamitsu Pharmaceutical Co is scheduled to report earnings on January 9, 2025, and the estimated EPS forecast is $0.90. See an overview of income statement, balance sheet, and cash flow financials.
